PET Imaging Platform
Total Trials
3
As Lead Sponsor
1
As Collaborator
2
Total Enrollment
228
NCT02437539
Evaluation of a New Radiotracer (68Ga-NOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography
Phase: Phase 1
Role: Collaborator
Start: May 31, 2015
Completion: Aug 31, 2015
NCT02681640
uPAR PET/CT for Preoperative Staging of Breast Cancer Patients
Phase: Phase 2
Start: Mar 31, 2016
Completion: Mar 31, 2017
NCT06474806
Safety and Diagnostic Performance of uPAR PET Imaging in Localised, Untreated Prostate Cancer
Role: Lead Sponsor
Start: Jun 1, 2024
Completion: Sep 1, 2025
Loading map...